<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="2" ids="27899">Cisplatin</z:chebi> is a highly effective <z:chebi fb="0" ids="35610">antineoplastic</z:chebi> agent used also in <z:e sem="disease" ids="C0740345" disease_type="Neoplastic Process" abbrv="">germ cell cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Thromboembolic complications like <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> have occasionally been reported </plain></SENT>
<SENT sid="2" pm="."><plain>CASE REPORT: A 46-year-old man with <z:mpath ids='MPATH_317'>seminoma</z:mpath> and without any cerebrovascular risk factors developed an <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> with complete right-sided <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> and global <z:hpo ids='HP_0002381'>aphasia</z:hpo>, during the second cycle of <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-based chemotherapy </plain></SENT>
<SENT sid="3" pm="."><plain>After exclusion of an <z:mp ids='MP_0001916'>intracerebral bleeding</z:mp>, a systemic thrombolysis was performed </plain></SENT>
<SENT sid="4" pm="."><plain>Further diagnostics revealed an <z:hpo ids='HP_0011009'>acute</z:hpo> occlusion of the left carotid internal artery with infarction in the territory of the middle cerebral artery </plain></SENT>
<SENT sid="5" pm="."><plain>The patient slowly recovered; however, a moderate <z:hpo ids='HP_0002381'>aphasia</z:hpo> and partial <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> persisted whereas the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was in complete remission </plain></SENT>
<SENT sid="6" pm="."><plain>Months later, the patient developed symptomatic <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> associated with <z:chebi fb="2" ids="27899">cisplatin</z:chebi>-based chemotherapy is rare, but may be disabling or even fatal </plain></SENT>
<SENT sid="8" pm="."><plain>With regard to the literature, several precautions are discussed to minimize the risk of these major side effects </plain></SENT>
</text></document>